Insights
More Articles
- Moderna's COVID-19 vaccine wins approval in Switzerland
- EMA to launch accelerated review for AZ COVID-19 vaccine
- Bangledesh company reaches COVID-19 vaccine deal
- Priority review granted for 15-valent pneumococcal vaccine
- Eli Lilly's donanemab promising in Alzheimer's disease
Moderna touts COVID-19 vaccine's durability of protection
Moderna CEO Stephane Bancel touted the potential durability of protection their company's COVID-19 vaccine could offer while speaking at an event last week. "The nightmare scenario that was described in the media in the spring with a vaccine only working a month or two is, I think, out of the window. We believe there will be protection potentially for a couple of years," Bancel said. PMLive (UK) (1/8)
Read full article now.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!